Digital maturity is essential for scientific engagement amid more complex therapies and spheres of influence. Nearly six in 10 life sciences products hitting the market are in specialty or rare disease categories.1 As scientific complexity grows, healthcare professionals (HCPs) and key opinion leaders (KOLs) seek science-based education via webinars, virtual medical … [Read more...]